Earnings Figures Preview: Lennar, Anterix, Aurora Cannabis, and High Tide
- June 10th, 2023
- 356 views
Several companies are expected to report their financial results on Wednesday, June 14, including:
Lennar Corporation (NYSE: LEN)(NYSE:LEN.B), a leading home construction and real estate development company, is set to announce its second-quarter fiscal 2023 earnings after the market closes.
Analysts expect earnings per share (EPS) of $2.31 on revenue of $7.17 billion.
$LEN closed at $114.20 on Friday, showing a slight increase of $0.83 (+0.73%).
Anterix Inc. (Nasdaq: ATEX), a provider of private broadband solutions for critical infrastructure industries, will release its fiscal 2023 fourth-quarter financial results before the market opens.
The consensus estimates a loss of $0.71 per share on revenue of $1.04 million.
On Friday, $ATEX closed at $33.34, experiencing a small decline of $0.27 (-0.80%).
Aurora Cannabis Inc. (Nasdaq: ACB), a prominent cannabis company, is scheduled to report its third-quarter and full fiscal year 2023 results before the market opens.
Analysts anticipate a loss of $0.05 per share on revenue of $48.68 million.
$ACB closed at $0.53 on Friday.
High Tide Inc. (Nasdaq: HITI), a retail-focused cannabis company, will release its financial and operational results for the second fiscal quarter of 2023 after financial markets close.
The consensus predicts a loss of $0.04 per share on revenue of $88.3 million.
On Friday, $HITI closed at $1.25, showing a minor decrease of $0.01 (-0.79%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Johnson & Johnson, Charles Schwab, Halliburton: Earnings Preview
January 18th, 2026Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026




Member Login